Collegium Pharmaceutical Shares Rise After 2025 Guidance

MT Newswires12:17 ET

Express News | Collegium Sees 2025 Net Product Revenues $735M-$750M, Adj. EBITDA $435M-$450M

BenzingaJan 8 08:10 ET

Collegium Pharma: 2025 Jornay PM Net Rev Expected to Be in Excess of $135 M >COLL

Dow JonesJan 8 08:02 ET

Express News | Collegium Pharmaceutical Outlook FY Adjusted Ebitda USD 435-450 Million

ReutersJan 8 08:00 ET

Press Release: Collegium Provides 2025 Financial Guidance and Business Update

Dow JonesJan 8 08:00 ET

Pulling Back 6.0% This Week, Collegium Pharmaceutical's NASDAQ:COLL) Three-year Decline in Earnings May Be Coming Into Investors Focus

Yahoo FinanceDec 25, 2024 05:45 ET